After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...

After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with ...

About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma ...

After pressure from the FTC, Teva has asked the FDA to delist hundreds of patents on products for asthma, diabetes, chronic obstructive pulmonary disease and for epinephrine autoinjectors, the agency ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

Supreme Group has consolidated two of the companies it bought during a nine-deal, 18-month splurge, combining Amendola ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

The new Lilly facilities—which include a $5 billion API plant near Richmond, Virginia, which was announced in September—are ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...